ArticleBMJ open2021

Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial.

Lucy Vivash et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.